In IVF (In Vitro Fertilization), how long after ovulation does the placenta start producing hormones in the absence of a functional corpus luteum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Placental Hormone Production in IVF Pregnancies

In IVF pregnancies, the placenta begins producing sufficient progesterone to sustain pregnancy by approximately 6-8 weeks after conception (8-10 weeks gestational age), though this transition is often delayed compared to natural pregnancies, particularly when the corpus luteum is absent or suppressed. 1, 2

Timeline of Luteal-Placental Transition

Natural Pregnancy vs. IVF

  • In spontaneous conceptions with a functional corpus luteum, the placenta gradually assumes progesterone production starting around 6-8 weeks post-conception, with the corpus luteum then regressing 1
  • In IVF pregnancies, particularly those using GnRH agonist protocols that suppress corpus luteum function, the luteal-placental shift is significantly delayed 3
  • Studies demonstrate that the luteal contribution to progesterone remains elevated throughout the first trimester in IVF pregnancies, obscuring the placental contribution for much longer than in natural pregnancies 3

Critical Early Pregnancy Period

  • The corpus luteum provides essential progesterone support for the first 6-8 weeks of pregnancy before placental takeover 1
  • In IVF cycles where normal hormones are suppressed, the corpus luteum does not produce adequate progesterone before the pregnancy test, necessitating exogenous supplementation 1
  • A delay in implantation of approximately 1.3 days has been observed in pregnancies after GnRH agonist-HMG treatment compared to other stimulation protocols, related to temporarily defective corpus luteum function 4

Clinical Implications for Progesterone Support

Duration of Supplementation

  • Progesterone supplementation is required in IVF cycles at least through the early pregnancy period until placental production is established 1, 2
  • The inadequate corpus luteum function in assisted reproduction results from both GnRH analogue use (which prevents the LH surge) and aspiration of granulosa cells during oocyte retrieval 2
  • Evidence suggests that in IVF pregnancies, serum progesterone levels remain significantly elevated up to 8 weeks post-conception even after discontinuing luteal support at 2 weeks, indicating sustained luteal contribution 3

Protocol-Specific Considerations

  • In IVF protocols with hypothalamic-pituitary suppression (0 corpus luteum), progesterone supplementation is absolutely critical throughout early pregnancy 5
  • Women in the 0 CL cohort show undetectable relaxin throughout pregnancy, including late gestation, indicating complete absence of corpus luteum function 5
  • In ovarian stimulation protocols with multiple corpora lutea, progesterone, plasma renin activity, and aldosterone show transient surges at 5-6 gestational weeks 5

Important Caveats

Timing Variability

  • The exact timing of adequate placental hormone production varies between individuals and IVF protocols 3, 5
  • The luteal-placental shift is obscured in IVF pregnancies, making it difficult to determine precisely when the placenta assumes full hormonal control 3
  • Measurement of the progesterone to 17-OHP ratio shows that in normal pregnancies this rises between 4-9 weeks, but does not change over the same period in IVF pregnancies, indicating delayed placental contribution 3

Clinical Practice Recommendations

  • Most IVF protocols continue progesterone supplementation through at least 8-10 weeks gestational age to ensure adequate support during the transition period 1, 2
  • Temporarily defective corpus luteum function is evidenced by measuring serum progesterone, estradiol, and 17-hydroxyprogesterone levels, which can be related to prolonged blockage of pituitary gonadotropic function after GnRH agonist use 4
  • The maternal milieu of IVF pregnancy is not physiologic compared to spontaneous conception, with specific perturbations varying according to IVF protocol and corpus luteum status 5

References

Research

The inadequate corpus luteum.

Reproduction & fertility, 2021

Research

Delayed luteo-placental shift of progesterone production in IVF pregnancy.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.